Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery Equipment, Technologies and Companies, 2006-2011

Table of Contents

1. What Cell Analysis is and What We Are Aiming for With This Research Project

• 1.1 Our Definition of the Cell Analysis Market
• 1.2 The Aim of This Research Report

2. Overview-- Current Market Status and R&D Status in Biotech and Pharma (Bio-Pharma) for Cell Analysis

• 2.1 Cell Based Screening & Analysis Helps Pharma Productivity
  • 2.1.1 Drug Making Productivity
  • 2.1.2 Increasing Use of Cell Based Screening and Analysis Platforms
• 2.2 Cell-Based Analysis Applications in Bio-Pharma Drug Discovery & Development
  • 2.2.1 Traditional Pharma Drug Discovery Paradigm & Compound Screening
  • 2.2.2 Drug Targets and Main Drug Target Classes
  • 2.2.3 Cell Assay Development - Bio-pharmas Make Their Own Assays
  • 2.2.4 High Throughput Screening (HTS) & High Content Screening (HCS)
  • 2.2.5 Toxicology Testing (Safety Screening)
• 2.3 Current Equipment & Tools and R&D for Cell Analysis
• 2.4 Current Technologies and Related R&D for Cell Based Screening-Analysis
• 2.5 Current Reagents & Assays and Related R&D for Cell Based Screening-Analysis
• 2.6 Main Competitors by Large, Medium and Start-up (Emerging Companies)

3. Trends and Directions of Cell Based Screening and Analysis Equipment and Technologies

• 3.1 Trends: Cell Screening Equipment
  • 3.1.1 Plate Imaging Equipment for Cell based HTS
  • 3.1.2 Imaging Cytometry Equipment for HCS/ HCA
  • 3.1.3 Emerging Developments In Cell Based Screening
• 3.2 Trends: Cell Screening Technologies
  • 3.2.1 Labeling Reagents and No-Wash Assays
  • 3.2.2 Cells as Reagents
  • 3.2.3 Stem Cells Used as a Drug Discovery Tool

4. Alliances & IP

• 4.1 Summary and Review of Major M&As, Alliances, or Deals
  • 4.1.1 M&A and Alliances at a Glance
  • 4.1.2 Leading M&A Acquirers
  • 4.1.3 Data Tables for M&As and Alliances Involving Cell-Based Analysis
• 4.2 Summary of Key Patent IP Involving Cell-Based Analysis

5. Market Size and Forecast 2006 to 2010

• 5.1 The Total Worldwide Cell-Based Screening-Analysis Market Size
• 5.2 Market Segments by Product Type and Revenues
  • 5.2.1 Major Market Segments by Main Product Areas
  • 5.2.2 Comparison of Major Market Segments by Market Shares, 2006 & 2010
  • 5.2.3 Equipment Segment by Product Type
  • 5.2.4 ' Consumables' Segment by Product Type
  • 5.2.5 Content Segment by Product Type
  • 5.2.6 Services Segment by Product Type
  • 5.2.7 ' Others' Segment by Product Type
• 5.3 Market Segments By Major Worldwide Regions
  • 5.3.1 Region Segments
  • 5.3.2 Comparison of Region Segments by Market Shares, 2006 & 2010
• 5.4 Outlook for Leading Commercial Vendors Market Share Rank

6. Activities of Cell Based Screening-Analysis Companies

• 6.1 Multiplatform Cell Screening/Analysis Systems
  • 6.1.1 to 6.1.7 Total 7 companies
• 6.2 Flow Cytometry Screening Systems
  • 6.2.1 to 6.2.4 Total 4 companies
• 6.3 High Content Screening/Analysis Cell Imaging Systems
  • 6.3.1 to 6.3.5 Total 5 companies
• 6.4 Cell-Based Screening Assays/Reagents
  • 6.4.1 to 6.4.5 Total 5 companies
• 6.5 Cell Screening Assays/Reagents
  • 6.5.1 to 6.5.3 Total 3 companies
• 6.6 Contract Research and Development Services
  • 6.6.1 to 6.6.3 Total 3 companies
• 6.7 Cell Screening/Analysis Software
  • 6.7.1 to 6.7.4 Total 4 companies

7. Conclusions: Findings & Opportunities

• 7.1 Important Findings
  • 7.1.1 Market Size and Growth
  • 7.1.2 Alliances and IP
  • 7.1.3 Bio-Pharma Product & Technology Users
  • 7.1.4 Equipment
  • 7.1.5 Services
• 7.2 The Cell-Based Screening & Analysis Business/ Tech Market Roadmap and Opportunities
  • 7.2.1 Major CBSA Products & Services Segments by Growth Rate
  • 7.2.2 Important Growth Areas Within Major Segments

8. Appendix

• 8.1 Company Contacts
• 8.2 Patent Data Tables

• Table 1. Equipment for Cell Based Screening and Analysis
• Table 2. Equipment Competitors by Large, Medium & Small Companies
• Table 3. Consumables Competitors by Large, Medium & Small Companies
• Table 4. Content Competitors by Large, Medium & Small Companies
• Table 5. Services Competitors by Large, Medium & Small Companies
• Table 6. Other Competitors by Large, Medium & Small Companies
• Table 7. Wide Field vs. Confocal HCS/ HCA Equipment
• Table 8. Confocal HCS/ HCA Imaging Equipment Used By Bio-Pharmas
• Table 9. Summary of Cell-based M&As & Alliances, Jan-2004 through Oct-2006
• Table 10. Summary of Cell-based M&As by Top Acquirers
• Table 11. M&As and Alliances, Through Oct. 2006
• Table 12. M&As and Alliances, 2005
• Table 13. M&As and Alliances for Cell-Based Screening and Analysis, 2004
• Table 14. CBA Related IP by No. of New Patents Issued, 2005 & 2006
• Table 15. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma.Drug Discovery & Development (BPDD)
• Table 16. WW Market by Major Segments & Revenues
• Table 17. WW Market by Major Segments & Shares, 2006 & 2010
• Table 18. ' Equipment' Segments by Product Type
• Table 19. ' Consumables' Segments by Type
• Table 20. ' Content' Segments by Type
• Table 21. ' Services' Segments by Type
• Table 22. The ' Others' Segment
• Table 23. CBSA Market by Major Worldwide Regions
• Table 24. Market by Major Worldwide Region Share, 2006 & 2010
• Table 25. Leading ' Equipment' Vendors by Est. Market Share Rank
• Table 26. Leading ' Consumables' Vendors by Est. Market Share Rank
• Table 27. Major CBSA Products & Services Segments by Growth Rate
• Table 28. ' Services' Sub-segments by Growth Rate
• Table 29. ' Consumables' Sub-segments by Growth Rate
• Table 30. ' Equipment' Sub-segments by Growth Rate
• Table 31. Company Contacts, Web Links and State/Country
• Table 32. Patent Data by Technology Type, Company, Patent and Title

• Figure 1. WW Cell Based Screening and Analysis by Products & Services
• Figure 2. Traditional Drug Discovery and Development Paradigm
• Figure 3. MDC FLIPR vs. Competing HTS Flash Luminescence Plate Imagers
• Figure 4. WW Cell-Based Screening-Analysis (CBSA) Market for Bio-Pharma. Drug Discovery & Development (BPDD)
• Figure 5. WW Market by Major Segments & Revenues
• Figure 6. WW Market by Major Segments & Shares, 2006 & 2010
• Figure 7. ' Equipment' Segments by Type
• Figure 8. ' Consumables' Segments by Type
• Figure 9. ' Content' Segments by Type
• Figure 10. ' Services' Segments by Type
• Figure 11. The ' Others' Segment
• Figure 12. CBSA Market by Major Worldwide Regions
• Figure 13. Market by Major Worldwide Region Share, 2006 & 2010
• Figure 14. A Typical High Content Screening Solution
• Figure 15. Molecular Devices Cell Based Screening Systems
• Figure 16. Cellomics Imaging System for High Content Screening and Analysis